180 Life Sciences closes $3M public offering of 4.6M shares and warrants at $0.65

FORUM MARKETS Inc

Offering of 4,615,385 shares (or equivalents) and warrants to purchase 4,615,385 shares at $0.65 per unit.
Gross proceeds ~$3M; net proceeds ~$2.6M after placement agent fees and expenses.
Proceeds to fund R&D and marketing authorization application for Dupuytren's Contracture in UK and possibly US.
Existing warrants for 4,448,713 shares amended: exercise price reduced from prior level to $0.83.
Placement agent A.G.P./Alliance Global Partners; 90-day lock-up for directors and officers.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

FORUM MARKETS Inc entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (effective 2023-08-09).

Action: entry
Agreement: underwriting
Counterparty: A.G.P./Alliance Global Partners
Effective: 2023-08-09

Exact text from the filing

On August 9, 2023, the Company also entered into a placement agency agreement (the “ Placement Agency Agreement ”) with A.G.P./Alliance Global Partners (the “ Placement Agent ”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

FORUM MARKETS Inc amended Warrant Amendment Agreement with the Institutional Investor (effective 2023-08-09).

Action: amendment
Counterparty: the Institutional Investor
Effective: 2023-08-09

Exact text from the filing

In connection with the Offering, the Company entered into a warrant amendment agreement (the “ Warrant Amendment Agreement ”), dated August 9, 2023, with the Institutional Investor, whereby the Company agreed to amend the following existing warrants held by such Institutional Investor

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

FORUM MARKETS Inc entered into Purchase Agreement with a certain institutional investor valued at approximately $3.0 million (effective 2023-08-09).

Action: entry
Agreement: equity purchase
Counterparty: a certain institutional investor
Value: approximately $3.0 million
Effective: 2023-08-09

Exact text from the filing

On August 9, 2023, 180 Life Sciences Corp., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with a certain institutional investor (the “ Institutional Investor ”) and agreed to issue and sell to certain purchasers, including the Institutional Investor, in a registered public offering (the “ Offering ”), an aggregate of: (i) 666,925 shares (the “ Shares ”) of the Company’s common stock, $0.0001 par value (the “ Common Stock ”), at a price of $0.65 per share

View on SEC.gov

273 material agreements filed in the last 30 days. Browse all material agreements →

FORUM MARKETS Inc filing history →

Source: SEC EDGAR

accession 0001213900-23-067810

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.